A detailed history of Bill Few Associates, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Bill Few Associates, Inc. holds 3,350 shares of NVO stock, worth $343,810. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,350
Previous 3,350 -0.0%
Holding current value
$343,810
Previous $478,000 16.74%
% of portfolio
0.14%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$122.71 - $146.91 $49,084 - $58,764
400 Added 13.56%
3,350 $478,000
Q1 2024

Apr 18, 2024

BUY
$102.11 - $135.92 $56,160 - $74,756
550 Added 22.92%
2,950 $378,000
Q3 2023

Oct 20, 2023

BUY
$90.94 - $199.54 $218,256 - $478,896
2,400 New
2,400 $218,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bill Few Associates, Inc. Portfolio

Follow Bill Few Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill Few Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bill Few Associates, Inc. with notifications on news.